Loading
Latest filing published 17 Nov 2021 for PROGENITY, INC., €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Damon Silvestry appears in our data through filings on Biora Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 15 August 2021 to 15 November 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 17 November 2021 came the latest disclosure, a share grant for €14k in Biora Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations